- Home
- SPNS vs KNSA Comparison
SPNS vs KNSA Comparison
Compare SPNS & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNS
- KNSA
- Stock Information
- Founded
- SPNS 1982
- KNSA 2015
- Country
- SPNS Israel
- KNSA United Kingdom
- Employees
- SPNS N/A
- KNSA N/A
- Industry
- SPNS Computer Software: Prepackaged Software
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- SPNS Technology
- KNSA Health Care
- Exchange
- SPNS Nasdaq
- KNSA Nasdaq
- Market Cap
- SPNS 1.9B
- KNSA 1.7B
- IPO Year
- SPNS 1992
- KNSA 2018
- Fundamental
- Price
- SPNS $27.55
- KNSA $21.09
- Analyst Decision
- SPNS Buy
- KNSA Strong Buy
- Analyst Count
- SPNS 3
- KNSA 5
- Target Price
- SPNS $36.00
- KNSA $36.60
- AVG Volume (30 Days)
- SPNS 180.9K
- KNSA 365.7K
- Earning Date
- SPNS 11-11-2024
- KNSA 10-29-2024
- Dividend Yield
- SPNS 2.06%
- KNSA N/A
- EPS Growth
- SPNS 19.80
- KNSA N/A
- EPS
- SPNS 1.27
- KNSA N/A
- Revenue
- SPNS $538,933,000.00
- KNSA $384,098,000.00
- Revenue This Year
- SPNS $9.55
- KNSA $60.05
- Revenue Next Year
- SPNS $7.07
- KNSA $36.32
- P/E Ratio
- SPNS $21.35
- KNSA N/A
- Revenue Growth
- SPNS 7.10
- KNSA 54.41
- 52 Week Low
- SPNS $25.30
- KNSA $15.52
- 52 Week High
- SPNS $41.22
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- SPNS 26.37
- KNSA 34.36
- Support Level
- SPNS $26.82
- KNSA $20.41
- Resistance Level
- SPNS $28.74
- KNSA $21.55
- Average True Range (ATR)
- SPNS 0.96
- KNSA 0.87
- MACD
- SPNS -0.81
- KNSA -0.14
- Stochastic Oscillator
- SPNS 5.54
- KNSA 21.90
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.